logo

For the Inventor, By the Inventor

Denver, CO, United States of America

V Michael Holers

This inventor holds 21 USPTO granted patents and 10 published patent applications and 5 EPO patents, primarily in Complement Biology. Top assignees: University of Colorado, Musc Foundation for Research Development, Alexion Pharmaceuticals, Inc.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: V Michael Holers. Retrieved from https://idiyas.com/inventor/v-michael-holers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 76.2

 

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 74(Granted Patents)


Location History:

  • Aurora, CO (US) (2019 - 2021)
  • Denver, CO (US) (2010 - 2022)

Company Filing History:

goldMedal17 out of 1,450 
 
University of Colorado
 patents
silverMedal8 out of 178 
 
Musc Foundation for Research Development
 patents
bronzeMedal2 out of 199 
 
Alexion Pharmaceuticals, Inc.
 patents
4. 1 out of 3,803 
 
Johns Hopkins University
 patents
5. 1 out of 90 
 
National Jewish Health
 patents
6. 1 out of 1 
 
Taligen Therapeutics, Inc.
 patent
where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
C3D Fragment
Complement Pathway
Antibody Conjugates
CR2 Targeting
Factor H
Non-invasive Detection
Hemolytic Anemias
Inflammation Modulation
Humaneered Antibodies
Fusion Proteins
Nanoparticles
Complement Activation
21 patents (USPTO):Explore Patents
1. RE49339 - Antibodies to the C3D fragment of complement component 3 (2022-12-19),
2. 11407820 - Modulating the alternative complement pathway (2022-08-09),
3. 11191851 - Anti-C3d antibody conjugates and methods of detecting complement activation (2021-12-07),
4. 10413620 - Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging (2019-09-17),
5. 10278986 - Antibody-siRNA conjugates and uses therefor (2019-05-07),
6. 10239937 - Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis (2019-03-26),
7. 10233235 - Modulating the alternative complement pathway (2019-03-19),
8. 9815890 - Antibodies to the C3d fragment of complement component 3 (2017-11-14),
9. 9650447 - Complement receptor 2 (CR2) targeting groups (2017-05-16),
10. 9259488 - Anti-C3d antibody conjugates and methods of detecting complement activation (2016-02-16),
11. 9212212 - Targeting complement factor H for treatment of diseases (2015-12-15),
12. 9096677 - Humaneered anti-factor B antibody (2015-08-04),
13. 8937046 - Modulating the alternative complement pathway (2015-01-20),
14. 8858945 - Three-dimensional structure of complement receptor type 2 and uses thereof (2014-10-14),
15. 8840868 - Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles (2014-09-23),

Title: The Innovative Journey of V Michael Holers

Introduction: V Michael Holers is a distinguished inventor based in Denver, Colorado. His groundbreaking work in the field of inventions has significantly contributed to advancements in various industries.

Latest Patents: V Michael Holers holds several patents in the areas of biotechnology and medical devices, showcasing his commitment to innovation and problem-solving.

Career Highlights: With a career spanning several decades, V Michael Holers has established himself as a leading figure in the world of inventors. His innovative solutions have garnered recognition and praise from peers and professionals alike.

Collaborations: Throughout his career, V Michael Holers has collaborated with top research institutions, universities, and companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge technologies.

Conclusion: V Michael Holers' passion for innovation and his dedication to pushing the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire future generations of inventors to think creatively and strive for excellence in their pursuits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…